What is Bioceres Crop Solutions' operating income?

Bioceres Crop Solutions' total operating income in 2025 was -$31.71 million, based on the following breakdown: Total Gross Profit: $99.54 million Total Operating Expenses: $131.25 million

Bioceres Crop Solutions (BIOX) Financials

$0.35 0.00 (0.00%)

Closing price 07/17/2026 04:00 PM Eastern

Extended Trading

$0.35 0.00 (-0.03%)

As of 07/17/2026 05:40 PM Eastern

Compare

Annual Income Statements for Bioceres Crop Solutions

This table shows Bioceres Crop Solutions' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	-4.91	0.69	6.07	6.26	31	19	6.50	-60
Consolidated Net Income / (Loss)	-14	-16	4.24	-3.82	-3.91	20	7.29	-59
Net Income / (Loss) Continuing Operations	9.40	0.69	6.29	-3.82	-1.37	19	7.29	-59
Total Pre-Tax Income	-25	7.67	6.44	11	14	19	11	-58
Total Operating Income	16	31	34	13	14	27	15	-32
Total Gross Profit	56	74	77	67	102	156	157	100
Total Revenue	133	161	171	207	328	415	462	332
Operating Revenue	133	161	171	207	328	415	462	332
Total Cost of Revenue	77	87	94	140	226	259	305	232
Operating Cost of Revenue	77	87	94	140	226	259	305	232
Total Operating Expenses	39	43	43	53	88	129	142	131
Selling, General & Admin Expense	35	39	38	48	77	113	124	123
Research & Development Expense	3.95	3.69	4.20	5.62	6.95	15	17	15
Other Operating Expenses / (Income)	-0.61	-0.37	0.31	0.28	3.28	0.20	1.50	-6.78
Total Other Income / (Expense), net	-19	-23	-26	-2.81	2.19	-9.71	-3.91	-26
Interest Expense	-	-	-	6.61	7.88	11	7.91	26
Other Income / (Expense), net	-19	-23	-26	3.80	10	1.58	4.00	0.64
Income Tax Expense	-11	6.99	2.21	14	18	-1.07	3.78	1.27
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	11	-	-	-10	-33	-0.68	0.79	0.71
Weighted Average Basic Shares Outstanding	28.10M	30.48M	0.00	41.10M	-	62.80M	62.85M	63.23M
Weighted Average Diluted Shares Outstanding	28.10M	30.48M	0.00	41.10M	-	62.80M	62.85M	63.23M
Weighted Average Basic & Diluted Shares Outstanding	-	60.96M	0.00	41.10M	-	62.80M	62.85M	63.23M

No quarterly income statements for Bioceres Crop Solutions are available.

This table details how cash moves in and out of Bioceres Crop Solutions' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Change in Cash & Equivalents	13	-86	35	-86	-81	63	2.93	-278
Net Cash From Operating Activities	18	31	9.32	32	30	85	42	14
Net Cash From Continuing Operating Activities	23	31	28	32	30	85	42	14
Net Income / (Loss) Continuing Operations	-14	-16	4.24	-3.82	-3.91	20	7.29	-59
Consolidated Net Income / (Loss)	-14	-16	4.24	-3.82	-3.91	20	7.29	-59
Depreciation Expense	2.23	2.45	2.58	3.05	3.77	4.83	9.18	5.99
Amortization Expense	2.14	2.38	2.15	2.39	4.16	11	12	11
Non-Cash Adjustments To Reconcile Net Income	41	42	33	28	26	35	51	56
Changes in Operating Assets and Liabilities, net	-7.78	0.07	-13	2.41	-0.37	13	-37	-0.13
Net Cash From Investing Activities	-8.22	-0.13	-7.80	-0.10	0.00	0.00	-29	0.00
Net Cash From Continuing Investing Activities	0.00	-0.13	-7.80	-0.10	0.00	0.00	-22	0.00
Net Cash From Financing Activities	-10	-117	34	-118	-111	-22	-10	-292
Net Cash From Continuing Financing Activities	-10	-117	34	-118	-111	-22	-10	-292
Repayment of Debt	-38	-111	-104	-113	-111	-17	-142	-288
Payment of Dividends	-	-	-	0.00	0.00	-0.45	-0.17	-0.07
Other Financing Activities, net	-1.79	-0.85	2.30	-1.42	-0.18	-4.77	-2.75	-3.21

No quarterly cash flow statements for Bioceres Crop Solutions are available.

This table presents Bioceres Crop Solutions' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Total Assets	240	197	242	298	395	518	818	853	764
Total Current Assets	88	85	88	144	211	298	397	409	308
Cash & Equivalents	1.68	2.22	3.45	43	36	33	48	44	33
Accounts Receivable	49	57	59	74	103	134	189	244	208
Inventories, net	31	19	27	29	61	126	140	126	88
Current Deferred & Refundable Income Taxes	1.70	2.08	-	-	-	-	9.44	0.66	1.86
Plant, Property, & Equipment, net	46	40	43	41	46	49	66	73	72
Plant, Property & Equipment, gross	46	40	43	41	46	49	66	73	72
Total Noncurrent Assets	106	71	109	111	147	175	363	363	359
Long-Term Investments	32	19	25	25	31	39	39	40	39
Goodwill	25	14	30	26	29	36	112	112	112
Intangible Assets	42	27	40	35	67	77	174	177	181
Noncurrent Deferred & Refundable Income Taxes	3.69	5.73	5.01	2.81	4.28	5.70	7.33	9.71	4.93
Other Noncurrent Operating Assets	0.77	0.24	5.32	16	16	18	30	25	21
Total Liabilities & Shareholders' Equity	240	197	242	298	395	518	818	853	764
Total Liabilities	163	164	180	237	304	360	488	501	468
Total Current Liabilities	69	119	42	62	86	139	178	179	253
Short-Term Debt	34	65	-	-	-	-	-	0.00	102
Accounts Payable	23	28	41	57	72	126	151	169	145
Current Deferred Revenue	1.20	1.01	1.07	2.87	6.28	5.90	27	5.85	5.72
Current Deferred & Payable Income Tax Liabilities	0.03	0.00	0.14	1.56	7.45	7.54	0.51	4.83	0.45
Total Noncurrent Liabilities	93	45	136	173	217	219	308	320	213
Long-Term Debt	41	26	0.00	43	173	158	244	260	158
Capital Lease Obligations	-	0.00	-	-	1.14	12	14	11	16
Noncurrent Deferred & Payable Income Tax Liabilities	26	14	21	17	26	29	36	35	30
Noncurrent Employee Benefit Liabilities	-	0.00	5.36	5.04	4.68	7.62	9.61	7.34	6.17
Other Noncurrent Operating Liabilities	1.42	0.85	110	108	12	13	4.99	6.93	2.16
Total Equity & Noncontrolling Interests	77	19	62	61	90	158	330	351	295
Total Preferred & Common Equity	36	47	47	46	68	127	299	315	265
Total Common Equity	0.00	0.00	47	46	68	127	299	315	265
Other Equity Adjustments	-	-	47	46	68	127	299	315	265
Noncontrolling Interest	41	19	15	15	23	31	32	36	30

No quarterly balance sheets for Bioceres Crop Solutions are available.

This table displays calculated financial ratios and metrics derived from Bioceres Crop Solutions' official financial filings.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
DEI Shares Outstanding	0.00	36,120,517.00	0.00	41,104,087.00	45,870,346.00	62,796,774.00	-	63,228,239.00
DEI Adjusted Shares Outstanding	0.00	36,120,517.00	0.00	41,104,087.00	45,870,346.00	62,796,774.00	-	63,228,239.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	0.02	0.00	0.15	0.68	0.31	-	-0.94
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	20.31%	6.17%	21.22%	58.88%	26.39%	11.41%	-28.25%
EBITDA Growth	0.00%	1,549.63%	5.86%	70.43%	43.70%	37.93%	-12.22%	-134.58%
EBIT Growth	0.00%	312.33%	10.77%	101.36%	43.01%	17.98%	-37.85%	-263.72%
NOPAT Growth	0.00%	-74.66%	704.20%	-121.56%	17.11%	819.78%	-71.20%	-325.05%
Net Income Growth	0.00%	-14.31%	125.90%	-190.18%	-2.31%	616.12%	-68.99%	-907.32%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	0.00%	68.68%	-69.95%	243.84%	-7.16%	184.47%	-50.70%	-66.82%
Free Cash Flow Firm Growth	0.00%	0.00%	-79.36%	-969.66%	62.80%	-248.30%	87.36%	158.11%
Invested Capital Growth	0.00%	-72.96%	9.85%	441.38%	29.21%	95.46%	7.15%	-7.12%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	42.25%	45.85%	45.12%	32.33%	31.10%	37.55%	34.03%	30.00%
EBITDA Margin	0.57%	7.78%	7.76%	10.91%	9.87%	10.77%	8.49%	-4.20%
Operating Margin	11.77%	19.35%	19.99%	6.44%	4.39%	6.58%	3.02%	-9.56%
EBIT Margin	-2.71%	4.78%	4.99%	8.28%	7.45%	6.96%	3.88%	-9.37%
Profit (Net Income) Margin	-10.72%	-10.19%	2.48%	-1.85%	-1.19%	4.86%	1.35%	-17.74%
Tax Burden Percent	56.70%	-213.15%	65.75%	-36.28%	-27.79%	105.59%	62.35%	102.21%
Interest Burden Percent	698.29%	100.00%	75.79%	61.52%	57.45%	66.15%	55.91%	185.27%
Effective Tax Rate	0.00%	91.03%	34.25%	136.28%	127.79%	-5.59%	37.65%	0.00%
Return on Invested Capital (ROIC)	8.93%	3.56%	64.11%	-4.12%	-1.76%	7.62%	1.68%	-4.28%
ROIC Less NNEP Spread (ROIC-NNEP)	-15.46%	-47.48%	132.81%	-1.70%	-1.67%	1.16%	0.31%	-23.01%
Return on Net Nonoperating Assets (RNNOA)	-82.62%	-43.70%	-57.21%	-0.94%	-1.38%	0.63%	0.16%	-13.92%
Return on Equity (ROE)	-73.69%	-40.14%	6.90%	-5.06%	-3.14%	8.25%	1.84%	-18.20%
Cash Return on Invested Capital (CROIC)	0.00%	118.41%	54.72%	-141.75%	-27.25%	-56.99%	-5.22%	3.10%
Operating Return on Assets (OROA)	-1.66%	3.50%	3.15%	4.95%	5.36%	4.32%	2.15%	-3.85%
Return on Assets (ROA)	-6.56%	-7.45%	1.57%	-1.10%	-0.86%	3.02%	0.75%	-7.28%
Return on Common Equity (ROCE)	0.00%	-23.29%	5.25%	-3.82%	-2.47%	7.19%	1.66%	-16.34%
Return on Equity Simple (ROE_SIMPLE)	-30.55%	-34.58%	9.17%	-5.64%	-3.07%	0.00%	1.99%	0.00%
Net Operating Profit after Tax (NOPAT)	11	2.79	22	-4.83	-4.01	29	8.69	-22
NOPAT Margin	8.24%	1.74%	13.15%	-2.34%	-1.22%	6.95%	1.88%	-6.69%
Net Nonoperating Expense Percent (NNEP)	24.38%	51.04%	-68.70%	-2.42%	-0.09%	6.47%	1.37%	18.73%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	4.90%	-	-3.88%
Cost of Revenue to Revenue	57.75%	54.15%	54.88%	67.67%	68.90%	62.45%	65.97%	70.00%
SG&A Expenses to Revenue	26.42%	24.43%	22.49%	23.03%	23.59%	27.22%	26.75%	37.10%
R&D to Revenue	2.96%	2.30%	2.46%	2.72%	2.12%	3.70%	3.72%	4.50%
Operating Expenses to Revenue	28.92%	26.50%	25.13%	25.88%	26.71%	30.97%	31.01%	39.56%
Earnings before Interest and Taxes (EBIT)	-3.61	7.67	8.50	17	24	29	18	-31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.76	13	13	23	32	45	39	-14
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	2.81	0.00	1.06
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	66.34	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	2.02	0.00	0.85
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	43.38	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	2.31%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	2.08	0.00	1.03
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	2.51	0.00	1.56
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	23.28	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	36.04	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	36.10	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	12.30	0.00	37.34
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	32.09
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	4.69	0.00	0.71	1.93	1.07	0.78	0.78	0.94
Long-Term Debt to Equity	1.32	0.00	0.71	1.93	1.07	0.78	0.78	0.59
Financial Leverage	5.34	0.92	-0.43	0.55	0.83	0.55	0.52	0.61
Leverage Ratio	4.52	5.39	4.40	4.58	3.67	2.73	2.45	2.50
Compound Leverage Factor	31.53	5.39	3.33	2.82	2.11	1.81	1.37	4.63
Debt to Total Capital	82.42%	0.00%	41.46%	65.91%	51.75%	43.78%	43.67%	48.37%
Short-Term Debt to Total Capital	59.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	17.88%
Long-Term Debt to Total Capital	23.28%	0.00%	41.46%	65.91%	51.75%	43.78%	43.67%	30.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	17.58%	23.82%	14.04%	8.51%	9.43%	5.43%	5.73%	5.21%
Common Equity to Total Capital	0.00%	76.18%	44.50%	25.58%	38.82%	50.79%	50.61%	46.42%
Debt to EBITDA	120.10	0.00	3.25	7.74	5.24	5.76	6.90	-19.86
Net Debt to EBITDA	92.01	0.00	-1.82	4.78	3.02	3.80	4.76	-14.68
Long-Term Debt to EBITDA	33.92	0.00	3.25	7.74	5.24	5.76	6.90	-12.52
Debt to NOPAT	8.28	0.00	1.92	-36.13	-42.39	8.93	31.16	-12.46
Net Debt to NOPAT	6.34	0.00	-1.08	-22.32	-24.41	5.90	21.47	-9.21
Long-Term Debt to NOPAT	2.34	0.00	1.92	-36.13	-42.39	8.93	31.16	-7.85
Altman Z-Score	0.00	0.00	0.00	0.00	0.00	1.98	0.00	0.75
Noncontrolling Interest Sharing Ratio	100.00%	41.97%	23.90%	24.57%	21.52%	12.86%	9.92%	10.22%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.72	2.11	2.33	2.46	2.14	2.23	2.28	1.22
Quick Ratio	0.50	1.50	1.88	1.62	1.20	1.33	1.61	0.95
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	93	19	-166	-62	-216	-27	16
Operating Cash Flow to CapEx	0.00%	0.00%	584.03%	0.00%	0.00%	0.00%	393.93%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-25.17	-7.86	-19.10	-3.42	0.61
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	4.85	3.77	7.50	5.27	0.52
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	4.85	3.77	7.50	3.93	0.52
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.61	0.73	0.63	0.60	0.72	0.62	0.55	0.41
Accounts Receivable Turnover	2.52	2.76	2.57	2.35	2.78	2.57	2.14	1.47
Inventory Turnover	3.04	3.73	3.30	3.10	2.42	1.95	2.29	2.18
Fixed Asset Turnover	3.09	3.84	4.04	4.73	6.93	7.22	6.64	4.57
Accounts Payable Turnover	3.05	2.55	1.91	2.16	2.29	1.87	1.91	1.48
Days Sales Outstanding (DSO)	144.80	132.23	142.12	155.54	131.23	141.97	170.86	248.32
Days Inventory Outstanding (DIO)	120.03	97.98	110.50	117.91	150.88	187.59	159.33	167.79
Days Payable Outstanding (DPO)	119.55	143.30	190.87	168.80	159.64	194.76	191.14	246.45
Cash Conversion Cycle (CCC)	145.27	86.90	61.75	104.65	122.47	134.80	139.05	169.66
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	123	33	37	198	256	500	536	500
Invested Capital Turnover	1.08	2.05	4.88	1.76	1.45	1.10	0.89	0.64
Increase / (Decrease) in Invested Capital	0.00	-90	3.28	162	58	244	36	-38
Enterprise Value (EV)	0.00	0.00	0.00	0.00	0.00	1,041	0.00	517
Market Capitalization	0.00	0.00	0.00	0.00	0.00	839	0.00	283
Book Value per Share	$0.00	$1.55	$1.28	$1.65	$3.10	$6.51	$5.00	$4.22
Tangible Book Value per Share	($1.46)	($0.73)	($0.41)	($0.69)	$0.35	$0.28	$0.43	($0.44)
Total Capital	110	62	104	265	328	588	621	572
Total Debt	91	0.00	43	175	170	257	271	277
Total Long-Term Debt	26	0.00	43	175	170	257	271	174
Net Debt	70	-29	-24	108	98	170	187	205
Capital Expenditures (CapEx)	0.00	0.00	1.60	0.00	0.00	0.00	11	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	30	43	40	90	125	171	185	125
Debt-free Net Working Capital (DFNWC)	32	46	82	126	158	219	229	157
Net Working Capital (NWC)	-33	46	82	126	158	219	229	55
Net Nonoperating Expense (NNE)	25	19	18	-1.01	-0.10	8.66	2.44	37
Net Nonoperating Obligations (NNO)	104	-29	-24	108	98	170	187	205
Total Depreciation and Amortization (D&A)	4.37	4.83	4.73	5.44	7.93	16	21	17
Debt-free, Cash-free Net Working Capital to Revenue	22.29%	26.64%	23.24%	43.36%	38.05%	41.13%	39.96%	37.53%
Debt-free Net Working Capital to Revenue	23.95%	28.79%	48.18%	60.80%	48.24%	52.73%	49.58%	47.39%
Net Working Capital to Revenue	-24.97%	28.79%	48.18%	60.80%	48.24%	52.73%	49.58%	16.56%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	36.12M	0.00	41.10M	0.00	62.80M	62.85M	63.23M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	0.00	36.12M	0.00	41.10M	0.00	62.80M	62.85M	63.23M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	36.12M	0.00	41.10M	0.00	62.80M	62.85M	63.23M
Normalized Net Operating Profit after Tax (NOPAT)	11	22	22	9.32	10	19	8.69	-22
Normalized NOPAT Margin	8.24%	13.54%	13.15%	4.51%	3.07%	4.60%	1.88%	-6.69%
Pre Tax Income Margin	-18.91%	4.78%	3.78%	5.09%	4.28%	4.60%	2.17%	-17.35%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	2.59	3.11	2.56	2.27	-1.17
NOPAT to Interest Expense	0.00	0.00	0.00	-0.73	-0.51	2.55	1.10	-0.84
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	2.59	3.11	2.56	0.93	-1.17
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-0.73	-0.51	2.55	-0.24	-0.84
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	2.24%	2.79%	-0.12%
Augmented Payout Ratio	0.00%	0.00%	0.73%	0.00%	0.00%	2.24%	14.53%	-0.12%

No quarterly metrics and ratios for Bioceres Crop Solutions are available.

Financials Breakdown Chart

Bioceres Crop Solutions Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Bioceres Crop Solutions' financial year ends in June. Their financial year 2025 ended on June 30, 2025.

Bioceres Crop Solutions' net income appears to be on an upward trend, with a most recent value of -$58.85 million in 2025, rising from -$14.31 million in 2018. The previous period was $7.29 million in 2024. View Bioceres Crop Solutions' forecast to see where analysts expect Bioceres Crop Solutions to go next.

Bioceres Crop Solutions' total operating income in 2025 was -$31.71 million, based on the following breakdown:

Total Gross Profit: $99.54 million
Total Operating Expenses: $131.25 million

Over the last 7 years, Bioceres Crop Solutions' total revenue changed from $133.49 million in 2018 to $331.80 million in 2025, a change of 148.6%.

Bioceres Crop Solutions' total liabilities were at $468.43 million at the end of 2025, a 6.5% decrease from 2024, and a 188.0% increase since 2017.

In the past 8 years, Bioceres Crop Solutions' cash and equivalents has ranged from $1.68 million in 2017 to $48.13 million in 2023, and is currently $32.70 million as of their latest financial filing in 2025.

Over the last 7 years, Bioceres Crop Solutions' book value per share changed from 0.00 in 2018 to 4.22 in 2025, a change of 422.4%.

Related Companies

Financial statements for NASDAQ:BIOX last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bioceres Crop Solutions (BIOX) Financials

Financials Breakdown Chart

Bioceres Crop Solutions Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bioceres Crop Solutions (BIOX) Financials

Annual Income Statements for Bioceres Crop Solutions

Quarterly Income Statements for Bioceres Crop Solutions

Annual Cash Flow Statements for Bioceres Crop Solutions

Quarterly Cash Flow Statements for Bioceres Crop Solutions

Annual Balance Sheets for Bioceres Crop Solutions

Quarterly Balance Sheets for Bioceres Crop Solutions

Annual Metrics And Ratios for Bioceres Crop Solutions

Quarterly Metrics And Ratios for Bioceres Crop Solutions

Financials Breakdown Chart

Bioceres Crop Solutions Financials - Frequently Asked Questions

When does Bioceres Crop Solutions' fiscal year end?

How has Bioceres Crop Solutions' net income changed over the last 7 years?

What is Bioceres Crop Solutions' operating income?

How has Bioceres Crop Solutions' revenue changed over the last 7 years?

How much debt does Bioceres Crop Solutions have?

How much cash does Bioceres Crop Solutions have?

How has Bioceres Crop Solutions' book value per share changed over the last 7 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools